2016-03-05T00:00:00.000-05:00
small molecule drugs,-0.637748
product candidates,0.476323
Director Donald J.,-0.285599
clinical stage biotechnology,-0.38639
earnings results,-0.267475
52-week low,-0.661926
stage biotechnology company,-0.38639
clinical trials,-0.726983
business’s stock,-0.325427
Asset Management LLC,0.284409
chief executive officer,0.233623
acute coronary syndrome,-0.70846
stock,-0.0210683
InvestorPlace Broker Center,0.555736
Vitae Pharmaceuticals,-0.262139
multiple disease areas,-0.707978
outperform rating,0.433949
DAFNA Capital Management,0.260279
personal trading style,0.598412
Zacks Investment Research,0.365222
average rating,0.344751
target price,0.375693
AnalystRatingsNetwork.com reports,-0.285477
Capital Management LLC,0.260279
Pharmaceuticals Inc Daily,0.429096
buy rating,0.39227
research note,0.390059
unmet medical needs,-0.625627
average price,0.191371
shares,0.00991699
Alzheimer’s disease,-0.726983
concise daily summary,0.513846
consensus target price,0.344751
stock broker,0.245696
clinical trial,-0.427227
autoimmune disorders,-0.807634
new position,0.284409
quarter,-0.0764706
